5th International Conference on Heart and Cardiovascular Diseases

Aortic and vascular disease encompass a spectrum of life-threatening conditions from acute Type A and B aortic dissection to asymptomatic thoracic and abdominal aortic aneurysms requiring rapid diagnosis, risk stratification, and increasingly, minimally invasive endovascular intervention. The Aortic Disease & Vascular Cardiology session at Heart Congress 2027 examines CT-based aortic morphology assessment for dissection and aneurysm surveillance, updated TEVAR and EVAR indication thresholds, the management of uncomplicated Type B dissection with thoracic endovascular aortic repair (TEVAR) versus optimal medical therapy, genetically triggered aortopathies including Marfan, Loeys-Dietz, and bicuspid aortic valve-associated aortopathy, peripheral arterial disease management including endovascular lower limb revascularisation, and carotid artery disease.

Key Discussion Areas:

• Acute aortic syndrome: diagnosis, classification, and emergency management
• TEVAR for Type B aortic dissection: uncomplicated vs. complicated indications
• Thoracic and abdominal aortic aneurysm: surveillance thresholds and intervention timing
• Genetically triggered aortopathies: Marfan, Loeys-Dietz, and bicuspid aortopathy
• Endovascular aortic repair (EVAR): long-term outcomes and endoleak management
• Peripheral arterial disease: diagnosis, medical therapy, and revascularisation
• Carotid artery disease: CEA vs. CAS and imaging assessment
• Aortic wall imaging: MRI, PET-CT, and inflammation in aneurysm progression

Why Attend This Session?

Cardiologists, vascular surgeons, interventional radiologists, cardiac imagers, and emergency physicians will benefit from updates on contemporary aortic and vascular disease management, endovascular technique evidence, surveillance protocols for inherited aortopathies, and multidisciplinary aortic team decision-making.

Related Topics:

• Cardiovascular Surgery & Perioperative Cardiac Care
• Cardiac Imaging & Advanced Diagnostics
• Cardiac Genetics & Inherited Cardiovascular Disorders
• Hypertension & Hypertensive Heart Disease
• Preventive Cardiology

Frequently Asked Questions:

1.When is TEVAR indicated for uncomplicated Type B aortic dissection?

Historically managed medically, uncomplicated Type B dissection is increasingly treated with preemptive TEVAR in high-risk anatomical and morphological subgroups including large aortic diameter, false lumen patency, and genetic connective tissue disorders to prevent late aortic complications including aneurysmal dilation and rupture, with the INSTEAD-XL trial supporting improved long-term outcomes.

2.What monitoring is required for patients with genetically triggered aortopathies?

Patients with Marfan syndrome, Loeys-Dietz syndrome, and bicuspid aortic valve-associated aortopathy require regular cross-sectional imaging (MRI preferred) of the entire aorta, beta-blocker or losartan therapy to reduce aortic growth rate, activity restriction guidance, and prophylactic surgical repair at lower diameter thresholds than sporadic aneurysms.